Basement membrane proteins in NF1-associated neurofibroma extracellular matrix characterize tumor development and treatment response to MEK inhibitor

被引：0
|
作者：
Jiang, C. [1 ]
Shipman, T. [1 ]
Wang, Y. [1 ]
McKay, R. [1 ]
Le, L. Q. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dermatol, Dallas, TX 75390 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
825
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 17 条
  • [1] Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor
    Jiang, Chunhui
    Kumar, Ashwani
    Yu, Ze
    Shipman, Tracey
    Wang, Yong
    McKay, Renee M.
    Xing, Chao
    Le, Lu Q.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (12):
  • [2] Targeting the extracellular matrix for NF1-associated neurofibroma treatment
    Chunhui Jiang
    Chinese Journal of Plastic and Reconstructive Surgery, 2024, 6 (02) : 87 - 93
  • [3] Stem cell origin and tumor microenvironment in NF1-associated neurofibroma genesis
    Le, L. O.
    Parada, L. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S111 - S111
  • [4] Susceptible Stages in Schwann Cells for NF1-Associated Plexiform Neurofibroma Development
    Le, Lu Q.
    Liu, Chiachi
    Shipman, Tracey
    Chen, Zhiguo
    Suter, Ueli
    Parada, Luis F.
    CANCER RESEARCH, 2011, 71 (13) : 4686 - 4695
  • [5] Adaptive and acquired signaling response to MEK inhibition in NF1-associated malignant peripheral nerve sheath tumor
    Wang, Jiawan
    Pollard, Kai
    Pratilas, Christine
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [6] Role of bromodomain extra terminal inhibitor (BETi) in combination with radiotherapy for the treatment of NF1-associated malignant peripheral nerve sheath tumor
    Gingrich, Alcia A.
    Landers, Sharon
    Bhalla, Angela
    Rodriguez-Aguayo, Cristian
    Lazcano, Rossana
    Satpati, Suresh
    Lebron-Torres, Alines
    Keung, Emily Z.
    Scally, Christopher P.
    Roland, Christina L.
    Hunt, Kelly K.
    Lyu, Heather
    Lillemoe, Heather
    Guadagnolo, Ashleigh
    Lazar, Alexander
    Slopis, John
    McCutcheon, Ian
    Livingston, John A.
    Farooqi, Ahsan
    Rai, Kunal
    Torres, Keila E.
    CANCER RESEARCH, 2024, 84 (06)
  • [7] p53 expression in neurofibroma and malignant peripheral nerve sheath tumor - An immunohistochemical study of sporadic and NF1-associated tumors
    Halling, KC
    Scheithauer, BW
    Halling, AC
    Nascimento, AG
    Ziesmer, SC
    Roche, PC
    Wollan, PC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (03) : 282 - 288
  • [8] Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor
    Cohen-Barak, Eran
    Toledano-Alhadef, Hagit
    Danial-Farran, Nada
    Livneh, Ido
    Mwassi, Banan
    Hriesh, Maysa
    Zagairy, Fadia
    Gafni-Amsalem, Chen
    Bashir, Husam
    Khayat, Morad
    Warrour, Nassim
    Sher, Osnat
    Marom, Daphna
    Postovsky, Sergey
    Dujovny, Tal
    Ziv, Michael
    Shalev, Stavit A.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (05) : 775 - 780
  • [9] EXTENT OF TUMOR BUT NOT LOCATION MAY BE PREDICTIVE OF LONGITUDINAL DISEASE SEVERITY IN CHILDREN WITH NF1-ASSOCIATED GLIOMAS REQUIRING TREATMENT
    Chaturvedi, Sneha
    Saxena, Arohi
    Hassan, Ahmad
    Brossier, Nicole
    NEURO-ONCOLOGY, 2022, 24 : 132 - 132
  • [10] Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells
    Varin, Jennifer
    Poulain, Laury
    Hivelin, Mikael
    Nusbaum, Patrick
    Hubas, Arnaud
    Laurendeau, Ingrid
    Lantieri, Laurent
    Wolkenstein, Pierre
    Vidaud, Michel
    Pasmant, Eric
    Chapuis, Nicolas
    Parfait, Beatrice
    ONCOTARGET, 2016, 7 (24) : 35753 - 35767
12